| Literature DB >> 26919428 |
Zhenyu Zhong1, Atsushi Umemura2, Elsa Sanchez-Lopez1, Shuang Liang3, Shabnam Shalapour1, Jerry Wong1, Feng He1, Daniela Boassa4, Guy Perkins4, Syed Raza Ali5, Matthew D McGeough5, Mark H Ellisman4, Ekihiro Seki6, Asa B Gustafsson7, Hal M Hoffman5, Maria T Diaz-Meco8, Jorge Moscat8, Michael Karin9.
Abstract
Nuclear factor κB (NF-κB), a key activator of inflammation, primes the NLRP3-inflammasome for activation by inducing pro-IL-1β and NLRP3 expression. NF-κB, however, also prevents excessive inflammation and restrains NLRP3-inflammasome activation through a poorly defined mechanism. We now show that NF-κB exerts its anti-inflammatory activity by inducing delayed accumulation of the autophagy receptor p62/SQSTM1. External NLRP3-activating stimuli trigger a form of mitochondrial (mt) damage that is caspase-1- and NLRP3-independent and causes release of direct NLRP3-inflammasome activators, including mtDNA and mtROS. Damaged mitochondria undergo Parkin-dependent ubiquitin conjugation and are specifically recognized by p62, which induces their mitophagic clearance. Macrophage-specific p62 ablation causes pronounced accumulation of damaged mitochondria and excessive IL-1β-dependent inflammation, enhancing macrophage death. Therefore, the "NF-κB-p62-mitophagy" pathway is a macrophage-intrinsic regulatory loop through which NF-κB restrains its own inflammation-promoting activity and orchestrates a self-limiting host response that maintains homeostasis and favors tissue repair.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26919428 PMCID: PMC4769378 DOI: 10.1016/j.cell.2015.12.057
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582